Global Therapeutic Drug Monitoring Market: Trends, Share, Size, Growth, Opportunity and Forecast 2022-2028

 

A multidisciplinary practice known as therapeutic drug monitoring involves measuring the amount of a drug in the bloodstream to maintain an effective concentration. It helps with dose adjustments in accordance with patient needs, avoids toxicity and adverse drug reactions (ADR), and helps identify the therapeutic failure. It is used particularly with medications with a limited therapeutic window, with high protein binding, and with potentially toxic metabolites. Therapeutic drug monitoring is a technique used by doctors and hospitals to increase the clinical benefits of a drug while reducing its toxic side effects, ultimately enhancing the patient's quality of life.

Therapeutic Drug Monitoring Market is a medical procedure that measures a patient's blood concentration of a specific drug at various points in time. It is used to keep a constant volume of medication in the bloodstream without having any toxic effects. Only drugs with a limited therapeutic window are those for which therapeutic drug monitoring is used. It is also applied to medications with pronounced pharmacokinetic variability. Therapeutic drug monitoring begins when medication is started and includes establishing a preliminary dosage schedule that is suitable for the patient's clinical state characteristics, such as age, body mass index, weight, organ function, and medication therapy.

The Therapeutic Drug Monitoring Market demand for goods and services is anticipated to rise in the upcoming years as a result of the pandemic situation brought on by the novel coronavirus outbreak. Researchers from the life sciences and pharmaceutical industries are increasingly concentrating on developing a reliable and efficient COVID-19 virus treatment. In order to assess the effectiveness and potency of the developed drugs, these drug discovery processes necessitate extensive testing. The pharmaceutical and clinical research laboratories are assisted in the process of developing new drugs by participants and manufacturers in the Therapeutic Drug Monitoring Market. These tools and equipment include calibrators and controls.

 Key Players

Roche Diagnostics, Thermo Fisher Scientific, Bio-Rad Laboratories, Siemens Healthcare Diagnostics, Beckmann Coulter, and Abbott Diagnostics are important market participants in the therapeutic drug monitoring sector. To expand the company's diagnostic portfolio, Danaher Corporation, the parent company of Beckman Coulter, purchased Cepheid in 2016 for $4 billion.